NBNúria Balanza

Núria Balanza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Núria Balanza has a total of 124 co-authors. Here are the top co-authors by number of shared publications:

  • Quique Bassat

    Affiliations Centro de Investigação em Saúde de Manhiça [CISM], Maputo, Mozambique, ISGlobal - Hospital Clínic, Universitat de Barcelona, Barcelona, Spain, Institutó Catalana de Recerca i Estudis Avançats [ICREA], Barcelona, Spain, Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain, CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain

    8 shared publications
  • Antonio Sitoe

    Centro Investigação em Saúde de Manhiça (CISM) , Maputo

    5 shared publications
  • Rosauro Varo

    Centro de Investigação em Saúde de Manhiça (CISM)

    5 shared publications
  • Bàrbara Baro

    ISGlobal, Barcelona, Spain

    4 shared publications
  • Kathleen Zhong

    Sandra A. Rotman Laboratories, Sandra Rotman Centre for Global Health, University Health Network–Toronto General Hospital , Toronto, Ontario , Canada

    4 shared publications
  • Andrea M. Weckman

    UHN-Toronto General Hospital, University of Toronto, Toronto, ON M5G 1L7, Canada

    3 shared publications

Latest Publications

  • Open Access

    Ongoing multi-country outbreak of carbapenem-resistant Enterobacter hormaechei ST1344 carrying bla NDM-5 in the European Union/European Economic Area, March 2025 to April 2026

    by Louise Roer, Mirco Sandfort, Sebastian Haller, Sarah A Roth, Lisa-Marie Höfken, Soheila Javadi, Núria Balanza, Amelie Friedsam, Silver A Wolf, Claus Østergaard, et al.

    In seven EU/EEA countries, the emergence of NDM-5-producing Enterobacter hormaechei ST1344 among patients has been detected. In minimum spanning tree analysis of core genome-multilocus sequence-typing (cgMLST) profiles, isolates cluster with ≤ 4 allelic differences. The outbreak includes 57 cases (29 female/28 male; median age: 73 years), which occurred between March 2025 and April 2026. Many were hospitalised (n = 45), some with extensive prior medical treatment, and only three reported travel abroad. A cross-border investigation, including coordinated exposure questionnaires, has not yet identified a source.

  • Open Access

    Epidemiology and Outcomes of Pediatric Fever in a Rural District of Southern Mozambique: 17 Years of Morbidity Surveillance

    by David Torres-Fernandez, Jessica Dalsuco, Cristina Garcia-Mauriño, Núria Balanza, Marta Valente, Sara Ajanovic, Rosauro Varo, Jaime Fanjul, Justina Bramugy, Antonio Sitoe, et al.

    Background: Pediatric febrile illnesses remain a leading cause of health care visits, morbidity, and mortality in low-resource settings. Their etiological diagnosis and outcome evaluation are challenging as available tools are limited. Herein, we describe the epidemiology, trends, and clinical outcomes of febrile pediatric outpatient clinic visits and inpatients during a 17-year-long period in Southern Mozambique. Methods: We retrospectively analyzed surveillance morbidity and demographic data from children <15 years old presenting with fever (≥37.5°C) at Manhiça District Hospital and 5 peripheral health posts from 2004 to 2020. We characterized diagnoses and clinical signs, stratified by outpatient clinic visits and hospitalizations, and calculated 7-day mortality odds, case fatality ratios (CFRs), and minimum community-based incidence rates. Results: A total of 664 223 outpatient visits and 23 166 hospitalizations were included. The median age (interquartile range) was 47.1 (20.0–92.3) months for outpatients and 21.2 (10.1–41.5) months for inpatients. The most frequent first encounter diagnoses included malaria (33.5%), upper (27.8%) and lower (10.1%) respiratory tract infections, and acute gastrointestinal infection (6.0%), whose frequencies showed a marked annual decline from 2004 to 2020, particularly among inpatients. All-cause 7-day mortality was 0.1% and 2.2% among outpatients and inpatients, respectively. Sepsis and meningitis were less common but presented the highest CFRs (9%–16%). Malnutrition and HIV infection were major contributors to inpatient mortality. Seizures, edema, dehydration, and reduced consciousness were strong predictors of death. Conclusions: Malaria, respiratory tract, and acute gastrointestinal infections represented the predominant causes of fever and mortality, with decreasing trends over time. This analysis underscores the value of epidemiological surveillance and the need for improved early diagnosis and clinical management tools for febrile children.


  • Open Access

    Paediatric healthcare in Manhiça district through a gender lens: a retrospective analysis of 17 years of morbidity and demographic surveillance data

    by Núria Balanza, Aura Hunguana, Sara Ajanovic, Rosauro Varo, Justina Bramugy, Teodimiro Matsena, Tacilta Nhampossa, Dan Ouchi, Arsénio Nhacolo, Jéssica Dalsuco, et al.

    Sex and gender are major drivers of health and well-being. Sex, defined as the biological and physiological differences between males, females, and intersex people, can influence disease susceptibility and progression. Gender refers to the socially constructed norms, roles, and behaviours for men/boys, women/girls, and other gender identities, which affects other determinants of health, health risk […]


  • Open Access

    Heparin-Binding Protein Stratifies Mortality Risk Among Ugandan Children Hospitalized With Respiratory Distress

    by Hridesh Mishra, Núria Balanza, Caroline Francis, Kathleen Zhong, Julie Wright, Andrea L Conroy, Robert O Opoka, Quique Bassat, Sophie Namasopo, Kevin C Kain, et al.

    Current prognostic tools do not reliably and objectively identify children with pneumonia at risk of a severe or life-threatening episode. Heparin-binding protein (HBP) is a host immune protein that is released in response to infection. We hypothesized that measuring HBP concentrations at hospital admission could help risk-stratify children with pneumonia and identify those at higher risk of an adverse prognosis. We evaluated the prognostic accuracy of HBP for predicting in-hospital mortality among children with respiratory distress, and whether HBP could improve the accuracy of validated composite clinical severity scores. Of 778 Ugandan children under 5 years of age and presenting with clinically defined pneumonia, 60 (7.7%) died during hospital admission. HBP concentrations at presentation were significantly higher in children with fatal outcomes (median, 76 ng/mL [interquartile range {IQR}, 41–150]) compared to children who survived (median, 31 ng/mL [IQR, 18–57]) (P < .001). Children with HBP >41 ng/mL on admission had an elevated risk of death (hazard ratio, 5.3 [95% confidence interval {CI}, 2.9–9.5]; P < .0001). In receiver operating characteristic (ROC) curve analysis, HBP concentrations distinguished between fatal and nonfatal outcomes (area under the ROC curve, 0.75 [95% CI, .66–.84]) and significantly improved the prediction provided by the Respiratory Index of Severity in Children, a composite clinical severity score (P = .0026). Measuring HBP at presentation could help identify children at risk of severe and fatal pneumonia. Adding HBP to clinical scores could improve the recognition and triage of children with pneumonia at risk of death.


  • Open Access

    Adjunctive rosiglitazone treatment for severe pediatric malaria: A randomized placebo-controlled trial in Mozambican children

    by Rosauro Varo, Valerie M. Crowley, Humberto Mucasse, Antonio Sitoe, Justina Bramugy, Lena Serghides, Andrea M. Weckman, Clara Erice, Rubao Bila, Pio Vitorino, et al.


  • Open Access

    Reply to Zayet et al

    by Núria Balanza, Caroline K Francis, Valerie M Crowley, Andrea M Weckman, Kathleen Zhong, Bàrbara Baro, Rosauro Varo, Quique Bassat, Kevin C Kain

    Núria Balanza, Caroline K Francis, Valerie M Crowley, Andrea M Weckman, Kathleen Zhong, Bàrbara Baro, Rosauro Varo, Quique Bassat, Kevin C Kain; Reply to Zayet


  • Open Access

    Neurofilament Light Chain as a Biomarker of Neuronal Damage in Children With Malaria

    by Núria Balanza, Caroline K Francis, Valerie M Crowley, Andrea M Weckman, Kathleen Zhong, Bàrbara Baro, Rosauro Varo, Quique Bassat, Kevin C Kain, Rosiglitazone Adjunctive Therapy for Severe Malaria in Children (ROSI) Study Group, et al.

    Malaria can cause brain injury. Neurofilament light chain (NfL) is a biomarker of neuronal damage. Here we examined longitudinal plasma NfL levels in children aged 1–12 years with uncomplicated and severe malaria from Mozambique. NfL levels were similar in all malaria cases at hospital admission. However, levels increased over time and the increment was significantly higher in severe malaria cases with neurological manifestations (ie, coma, impaired consciousness, or repeated seizures). NfL may be useful to identify and quantify brain injury in malaria.


  • Open Access

    Prognostic accuracy of biomarkers of immune and endothelial activation in Mozambican children hospitalized with pneumonia

    by Núria Balanza, Clara Erice, Michelle Ngai, Chloe R McDonald, Andrea M Weckman, Julie Wright, Melissa Richard-Greenblatt, Rosauro Varo, Elisa López-Varela, Antonio Sitoe, et al.

    Pneumonia is a leading cause of child mortality. However, currently we lack simple, objective, and accurate risk-stratification tools for pediatric pneumonia. Here we test the hypothesis that measuring biomarkers of immune and endothelial activation in children with pneumonia may facilitate the identification of those at risk of death. We recruited children <10 years old fulfilling WHO criteria for pneumonia and admitted to the Manhiça District Hospital (Mozambique) from 2010 to 2014. We measured plasma levels of IL-6, IL-8, Angpt-2, sTREM-1, sFlt-1, sTNFR1, PCT, and CRP at admission, and assessed their prognostic accuracy for in-hospital, 28-day, and 90-day mortality. Healthy community controls, within same age strata and location, were also assessed. All biomarkers were significantly elevated in 472 pneumonia cases versus 80 controls (p<0.001). IL-8, sFlt-1, and sTREM-1 were associated with in-hospital mortality (p<0.001) and showed the best discrimination with AUROCs of 0.877 (95% CI: 0.782 to 0.972), 0.832 (95% CI: 0.729 to 0.935) and 0.822 (95% CI: 0.735 to 0.908), respectively. Their performance was superior to CRP, PCT, oxygen saturation, and clinical severity scores. IL-8, sFlt-1, and sTREM-1 remained good predictors of 28-day and 90-day mortality. These findings suggest that measuring IL-8, sFlt-1, or sTREM-1 at hospital presentation can guide risk-stratification of children with pneumonia, which could enable prioritized care to improve survival and resource allocation.


  • Open Access

    Biomarkers of Intestinal Injury and Dysfunction: Adding New Possibilities to Current Methods for Risk Stratification of Children with Malaria Disease

    by Núria Balanza, Elisa López-Varela, Bàrbara Baro, Quique Bassat

    Malaria remains, in 2022, a major cause of pediatric preventable mortality, with its major burden disproportionately circumscribed to sub-Saharan African countries. Although only ~1 to 2% of malaria cases can be considered severe and potentially life threatening, it is often challenging to identify them so as to prioritize adequate health care and resources.


  • Open Access

    Impact of COVID-19 Lockdown on the Nasopharyngeal Microbiota of Children and Adults Self-Confined at Home

    by Muntsa Rocafort, Desiree Henares, Pedro Brotons, Cristian Launes, Mariona Fernandez de Sevilla, Victoria Fumado, Irene Barrabeig, Sara Arias, Alba Redin, Julia Ponomarenko, et al.

    The increased incidence of COVID-19 cases and deaths in Spain in March 2020 led to the declaration by the Spanish government of a state of emergency imposing strict confinement measures on the population. The objective of this study was to characterize the nasopharyngeal microbiota of children and adults and its relation to SARS-CoV-2 infection and COVID-19 severity during the pandemic lockdown in Spain. This cross-sectional study included family households located in metropolitan Barcelona, Spain, with one adult with a previous confirmed COVID-19 episode and one or more exposed co-habiting child contacts. Nasopharyngeal swabs were used to determine SARS-CoV-2 infection status, characterize the nasopharyngeal microbiota and determine common respiratory DNA/RNA viral co-infections. A total of 173 adult cases and 470 exposed children were included. Overall, a predominance of Corynebacterium and Dolosigranulum and a limited abundance of common pathobionts including Haemophilus and Streptococcus were found both among adults and children. Children with current SARS-CoV-2 infection presented higher bacterial richness and increased Fusobacterium, Streptococcus and Prevotella abundance than non-infected children. Among adults, persistent SARS-CoV-2 RNA was associated with an increased abundance of an unclassified member of the Actinomycetales order. COVID-19 severity was associated with increased Staphylococcus and reduced Dolosigranulum abundance. The stringent COVID-19 lockdown in Spain had a significant impact on the nasopharyngeal microbiota of children, reflected in the limited abundance of common respiratory pathobionts and the predominance of Corynebacterium, regardless of SARS-CoV-2 detection. COVID-19 severity in adults was associated with decreased nasopharynx levels of healthy commensal bacteria.